- All sections
- C - Chemistrymetallurgy
- C07D - Heterocyclic compounds
- C07D 457/02 - Heterocyclic compounds containing indolo [4, 3-f, g] quinoline ring systems, e.g. derivatives of ergoline, of the formula: , e.g. lysergic acid with hydrocarbon or substituted hydrocarbon radicals, attached in position 8
Patent holdings for IPC class C07D 457/02
Total number of patents in this class: 12
10-year publication summary
|
1
|
0
|
1
|
0
|
0
|
0
|
0
|
2
|
1
|
0
|
| 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
Principal owners for this class
| Owner |
All patents
|
This class
|
|---|---|---|
| Regents of the University of Minnesota | 2682 |
2 |
| The Regents of the University of California | 19544 |
1 |
| Sandoz Ltd. | 3 |
1 |
| Axxonis Pharma AG | 2 |
1 |
| Farmitalia Carlo ERBA S.p.A. | 6 |
1 |
| Florida State University Research Foundation, Inc. | 710 |
1 |
| Lek Pharmaceuticals d.d. | 210 |
1 |
| Resolution Chemicals Limited | 11 |
1 |
| University of Pittsburgh - Of the Commonwealth System of Higher Education | 3052 |
1 |
| Xoc Pharmaceuticals, Inc. | 11 |
1 |
| Far Biotech, Inc. | 1 |
1 |
| Other owners | 0 |